Multiple sclerosis and Urine discoloration

Summary:

Urine discoloration is found among people with Multiple sclerosis, especially for people who are male, 50-59 old.

The study analyzes which people have Urine discoloration with Multiple sclerosis. It is created by eHealthMe based on reports of 6 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

6 people who have Multiple Sclerosis and Urine Discoloration are studied.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 2,125 drugs and 1,309 conditions by eHealthMe.

What is Urine discoloration?

Urine discoloration is found to be associated with 705 drugs and 69 conditions by eHealthMe.

Number of Urine discoloration in Multiple sclerosis reports submitted per year:

Would you have Urine discoloration when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Urine Discoloration *:

female: 50 %
male: 50 %

Age of people who have Multiple Sclerosis and experienced Urine Discoloration *:

Common drugs taken by these people *:

Common symptoms for these people *:

Weight Decreased: 2 people, 33.33%
Hepatitis Acute: 2 people, 33.33%
Flatulence (flatus expelled through the anus): 1 person, 16.67%
Abdominal Distension: 1 person, 16.67%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 1 person, 16.67%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 1 person, 16.67%
Consciousness - Decreased: 1 person, 16.67%
Drug Ineffective: 1 person, 16.67%
Faeces Discolored: 1 person, 16.67%
Fibrin D Dimer Increased: 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Urine discoloration?

Check whether Urine discoloration is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

Related studies

Treatments, associated drugs and conditions:

Multiple sclerosis (734,937 reports)
Urine discoloration (2,989 reports)

COVID vaccines that are related to Urine discoloration:

Common drugs associated with Urine discoloration:

Baycol: 461 reports
Rezulin: 248 reports
Zocor: 109 reports

All the drugs that are associated with Urine discoloration:

Urine discoloration (705 drugs)

All the conditions that are associated with Urine discoloration:

Urine discoloration (69 conditions)

How the study uses the data?

The study is based on Urine discoloration and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.